1596348-32-1

1596348-32-1 structure
1596348-32-1 structure
  • Name: KDM5-C70
  • Chemical Name: 4288BE400F
  • CAS Number: 1596348-32-1
  • Molecular Formula: C17H28N4O3
  • Molecular Weight: 336.429
  • Catalog: Signaling Pathways Epigenetics Histone Demethylase
  • Create Date: 2018-06-21 17:53:30
  • Modify Date: 2024-01-10 16:40:42
  • KDM5-C70 is an ethyl ester derivative of KDM5-C49 and a potent, cell-permeable and pan-KDM5 histone demethylase inhibitor. KDM5-C70 has an antiproliferative effect in myeloma cells, leading to genome-wide elevation of H3K4me3 levels[1][2].

Name 4288BE400F
Synonyms 4288BE400F
4-Pyridinecarboxylic acid, 2-[[[2-[[2-(dimethylamino)ethyl]ethylamino]-2-oxoethyl]amino]methyl]-, ethyl ester
Ethyl 2-{[(2-{[2-(dimethylamino)ethyl](ethyl)amino}-2-oxoethyl)amino]methyl}isonicotinate
Description KDM5-C70 is an ethyl ester derivative of KDM5-C49 and a potent, cell-permeable and pan-KDM5 histone demethylase inhibitor. KDM5-C70 has an antiproliferative effect in myeloma cells, leading to genome-wide elevation of H3K4me3 levels[1][2].
Related Catalog
Target

KDM5 histone demethylase[1][2]

In Vitro KDM5-C70 (10-9-10-5 M; 7 days; MM.1S myeloma cells) treatment shows antiproliferative effects after 7 days of treatment at elevated concentrations (estimated 50% reduction of viability/proliferation for KDM5-C70 at ~20 μM)[1]. KDM5-C70 (50 μM; 7 days; MM.1S myeloma cells) treatment decreases the level of phosphorylation of retinoblastoma protein (Rb), while leaving the total level of phosphorylated Rb (pRb) unchanged, indicating impairment of cell cycle progression[1]. Chromatin immunoprecipitation followed by next-generation sequencing shows an increase in H3K4me3 levels around transcription start sites with KDM5-C70 but little change with GSK467A at 50 μM inhibitor concentrations[1]. Cell Viability Assay[1] Cell Line: MM.1S myeloma cells Concentration: 10-9-10-5 M Incubation Time: 7 days Result: Showed antiproliferative effects after 7 days of treatment at elevated concentrations. Western Blot Analysis[1] Cell Line: MM.1S myeloma cells Concentration: 50 μM Incubation Time: 7 days Result: Decreased the level of phosphorylation of retinoblastoma protein (Rb).
References

[1]. Johansson C, et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. Nat Chem Biol. 2016 Jul;12(7):539-45.

[2]. Blair LP, et al. KDM5 lysine demethylases are involved in maintenance of 3'UTR length. Sci Adv. 2016 Nov 18;2(11):e1501662.

Density 1.1±0.1 g/cm3
Boiling Point 466.6±45.0 °C at 760 mmHg
Molecular Formula C17H28N4O3
Molecular Weight 336.429
Flash Point 236.0±28.7 °C
Exact Mass 336.216156
LogP 0.75
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.525
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.